|

NPC1-Placebo/Control Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Observational period

Pipeline

Phase 1/2: 1

Top Sponsors

  • Massachusetts General Hospital1

Indications

  • Subjective Cognitive Complaints (SCCs)1
  • Alzheimer's Disease1
  • Alzheimer Disease1
  • Mild Cognitive Impairment (MCI)1

Boston, Massachusetts1 trial

Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Massachusetts General Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.